Qube Research & Technologies (QRT)
ITRM

Qube Research & Technologies (QRT)’s Iterum Therapeutics ITRM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,276
Closed -$154K – 2528
2021
Q1 		$154K Buy
+7,276
New +$173K ﹤0.01% 1693

Other funds holding ITRM

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ITRM Position: Q2 2021 in Review

Qube Research & Technologies (QRT) sold out of Iterum Therapeutics (ITRM) in Q2 2021, closing a stake of 7,276 shares — an estimated $154K sold.

Qube Research & Technologies (QRT) first reported a position in ITRM in Q1 2021 and held it in 1 quarter. The position peaked at $154K in Q1 2021. 44 funds tracked by Wall St. Rank hold ITRM as of Q2 2021.

  • Qube Research & Technologies (QRT) reported no remaining Iterum Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 7,276 Iterum Therapeutics shares in Q2 2021, an estimated $154K.
  • Qube Research & Technologies (QRT) first reported a position in Iterum Therapeutics in Q1 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Iterum Therapeutics position peaked at $154K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2021, filed 13 Aug 2021.